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ABSTRACT

Graphene field-effect transistor (GFET) is becoming an increasingly popular biosensing
platform for monitoring health conditions through biomarker detection. Moreover, the graphene’s
2-dimensional geometry makes it ideal for implementing flexible or wearable electronic devices.
By using a GFET platform as a biosensor, users can easily monitor numerous health conditions. A
sweat-based biosensor can non-invasively monitor levels of proteins in the body and alert the user
to possible issues such as a steep increase or decrease in a particular protein. By creating a platform
that can be used as a wearable biosensor, it allows for rapid results and a cheaper way to provide
clinical quality data about one’s health conditions.
This thesis presents a novel approach for creating a low cost, reliable and selective,
wearable biosensor for real-time observation and tracking of the levels of the protein biomarker
Interleukin-6 (IL-6). A printable graphene transistor-based biosensor is created by using a PCB
printer on a flexible Kapton substrate. The conductive channel of the GFET is created using a
chemical vapor deposition (CVD)-grown graphene layer. By functionalizing (or modifying) the
graphene surface with biorecognition elements such as antibodies or aptamers in the channel of
the device, the GFET can operate as a biosensor. When various levels of IL-6 were introduced into
the GFET device, the target proteins bind to the aptamers causing a change in the charge carrier
concentration. The device is able to monitor in real-time the levels of IL-6 by observing the drainto-source current of the GFET which correlates to the IL-6 concentration being measured. The
device implemented contains an integrated current meter which is one of the building blocks for
creating a wearable electronic biosensor.
xii

CHAPTER 1: INTRODUCTION
1.1.

OVERVIEW
The development of cheaper, more reliable, and rapid-result biosensors and devices cover

a wide range of research topics in the health and bioelectronics fields. There are many types of
biosensors including optical, electrochemical, electrical, piezoelectric, thermal and Field-Effect
Transistor (FET)-based sensors. While each of these sensors have benefits and drawbacks, the
FET-based biosensors are growing more popular as they offer many advantages such as highly
sensitive measurements, portable instrumentation, easy operation, and low cost [6], [28], [40],
[54]. More specifically, Graphene-based FETs have proven to make highly effective biosensors
with extremely high sensitivity, flexibility, and rapid results. Graphene is a two-dimensional
material, as it is a single atomic layer of graphite, which lends itself to being highly mechanically
flexible, [37]-[38], [54] which is beneficial in terms of creating a wearable biosensor.
The fabrication of a wearable device creates many requirements to be met in terms of
mechanical characteristics as well as the standard electrical characteristics necessary for a
biosensor. Beginning with the substrate, the device must be bendable and able to conform to the
skin; however, it should be rigid enough not to tear while still allowing for full mobility. These
requirements have created the need for further investigation into electrode fabrication. The
electrodes must be easily integrated with a variety of substrates during the fabrication process. The
electrodes must also be bendable as they will be affixed to the substrate. After fabricating the
electrodes on the selected substrate, the GFET also must meet a plethora of sensing requirements
in order to successfully operate as a biosensor. The GFET will have to be able to detect a
biomarker, which in this application will be the protein Interleukin-6 (IL-6). In addition, the device
1

must show a concentration-dependent response to the IL-6, otherwise there is no correlation
between the device and biomarker. The device must also be selective to our target biomolecule
exclusively while not responsive to other possible interfering species. Finally, the biosensor must
be able to operate in real-time as a wearable device that is portable and gives both rapid and reliable
detection results.
1.2.

GFET AS A BIOSENSOR
Graphene-based FETs are highly advantageous for creating simple yet reliable biosensors

and thus are increasing in popularity as a sensing platform. Graphene-based FETs have been used
in a wide variety of sensing applications for an assortment of biomarkers. For example, GFETs
have been used to detect proteins [4], [6], [80-83], DNAs [1], glucose [54], etc. GFETs function
as biosensors effectively because biomarker and protein levels are able to be tracked through the
device characteristics. By using GFET platforms as biosensors, point-of-care testing (POCT),
which is highly sought-after, can be accomplished. POCT is when medical care is provided in
more patient-geared locations such as their homes or even bedside as opposed to a medical facility
[8], [9]. POCT requires devices that provide sophisticated results and accuracy while being low
cost, simple to operate, and that reduce the time to obtain the results [13]. Moreover, GFETs have
proven to provide a platform that can do just that and therefore are a competitive option for POCT
applications.
1.3.

MOTIVATION
Many people around the globe suffer from diseases and sicknesses which need to be closely

monitored and often tracked continuously in order to keep them under control. The pandemic that
people are dealing with world-wide right now is just one of many examples of how important fast
and reliable testing and detection of an illness can be. At the moment, certain tests can take days
2

for patients to receive results and COVID-19 can spread incredibly quickly. Therefore, in order to
contain the spread of the virus, rapid and trustworthy testing is needed. Diseases such as
tuberculosis, which is the leading infectious disease killer in the world, further demonstrate the
need for rapid and reliable detection of disease biomarkers. According to the CDC, in 2018, ten
million people suffered from tuberculosis but over three million of those cases went undiagnosed
[14]. Breast cancer is yet another life-threatening disease that requires early-action testing and
diagnosis for effective treatment. Early detection of breast cancer has proven to allow for increased
available treatment options, increased survival, and improved quality of life [15]. While there are
currently individual tests that detect each of these different diseases, it is necessary to further
increase the reliability, speed, and accessibility to testing of all diseases.
Biosensors are becoming an increasingly popular device to be used in order to help
monitor, track, and treat a plethora of diseases, sicknesses, and conditions. GFET sensors can be
produced for low cost, meaning they can be mass produced and thus could become widely
available as a new way to monitor one’s health. In addition, sensors mounted on the skin have the
ability to provide quality data to the user about a wide variety of biomarkers without the patient
ever having to visit a doctor’s office. Thus, in the future, GFET devices could be used as low cost,
rapid, wearable biosensors that will allow for the user to have more flexibility in their day-to-day
life, all while knowing that any conditions they may have are continuously being monitored.
1.4.

THESIS OBJECTIVES
The goal of this thesis is to develop an in-house PCB printed graphene-based field-effect

transistor biosensor with high sensitivity for Interleukin-6. The transistor is to be used as a
wearable device and thus it should be flexible as well as be a stand-alone device. The specific
objectives of this work are the following:
3

1. Develop a printable graphene field-effect transistor (GFET)-based biosensor on a flexible
platform.
2. Demonstrate the detection of a biomarker, specifically Interleukin-6 (IL-6), using the printable
GFET-based platform modified with aptamers as target-binding receptors.
3. Characterize the limit of detection and selectivity of the graphene-based sensor.
4. Demonstrate the real-time detection of the biomarker.
5. Characterize the GFET transfer (current-voltage) characteristic curve while the substrate is
under mechanical stress.
6. Implementation of an integrated current measurement system for the device characterizations
(in collaboration with Prof. Md. Shaad Mahmud’s group).
1.5.

THESIS OUTLINE
Chapter 2 gives background information on biosensors and electrolyte-gated GFET

devices. The chapter also details sensing principles such as Dirac voltage, Debye length, and
functionalization and immobilization of the device using PBASE and aptamers respectively.
Chapter 3 outlines the exact materials, methods and procedures that were followed during the
research process. The fabrication of the flexible and printable GFET is detailed from printing to
graphene deposition. Chapter 4 discusses the optimization of the device as well as the process of
functionalizing the graphene surface to be used as a selective biosensor. Chapter 5 describes the
detection of the target biomarker IL-6 with the GFET biosensor in both a static and real-time
measurement mode. This chapter also analyzes the device in terms of selectivity and reliability
under mechanical stress. Chapter 6 details the integration of an internal microcontroller that is used
to measure and record the current responses. Chapter 7 provides the conclusion and future outlook
of this research.
4

CHAPTER 2: THEORETICAL BACKGROUND
2.1.

OVERVIEW
Biosensors and health monitors are used to observe biomarkers and conditions occurring

in the body. Humans rely on health monitoring systems for a plethora of information including
disease diagnosis and progression. Sensors that can be worn on the body and continuously monitor
these conditions could provide earlier notice to the user that there are issues which need to be
addressed. Sensors depend on sensitivity, reliability, and rapid timing to remain as a key system
for monitoring. Graphene-based FET devices are known for supporting highly sensitive and
reliable devices which is why their use for sensors is a wide topic of research. In this chapter, the
basic working principle of a graphene FET, its application as a biosensing platform and the
theoretical background on aptamer-based target recognition and detection are discussed.
2.2.

BIOSENSORS
A biosensor is a device which monitors for biomarkers and health conditions. A biosensor

can be defined as an analytical device that incorporates a biological material such as
microorganism, antibody, cell receptor, etc. and interprets the biomarker quantity into a
proportional, measurable signal [87]. Biosensors similar to the one used in this application utilize
a biological element along with a physicochemical transducer which converts a bio-recognition
event into a proportional electronic signal [25]. Furthermore, a biosensor is comprised of two main
parts, a bioreceptor and a transducer [25]. The first portion of the sensor is the bioreceptor where
the target biomolecule either interact or bind with a receptor causing physical changes in the
structures of the bioreceptor [25]. The second portion of the sensor is the transducer which
5

characterizes the changes occurring physically and creates measurable signals that are proportional
to the concentration of the target molecules bound to the receptors [25]. Biosensors come in many
different forms including optical, thermal, piezoelectric, quartz crystal microbalance (QCM), and
electrochemical [25]. The sensors are classified based on the transducer type that is being used in
order to convert the target recognition event into a readable signal.
Current state of the art of graphene-based biosensors includes extensive work on rigid
substrates and often using lithography, etching and lift-off techniques to fabricate such devices.
Many research groups have presented working graphene-based electronics, specifically as nano
sensors [4], [10], [82]. As the name suggests, nano sensors get their name from both their physical
size and the quantities of targets they are able to detect [84]. Nano sensors’ dimensions are
typically in the nanometer range while their limit of detection can be in the nanomolar range or
even lower [4], [10], [84]. These nano sensors have provided clear results supporting that they can
accurately measure changes in concentration of biomarkers such as proteins or DNA. In previous
work, the FET is typically fabricated on a silicon oxide (SiO2) coated silicon wafer substrate using
standard nanofabrication techniques as mentioned above. Biosensors that detect DNAs or proteins
are also widely used, where DNA sensing uses peptide nucleic acid (PNA) probes as the receptor
to bind to the graphene and protein sensing uses specific aptamers [1], [4]. These devices show
not only a range of targets that can be sensed, but also demonstrate the highly sensitive and
selective nature of the GFET-based sensing platform.
In more recent work, the progression of GFETs on a variety of substrates has been at the
forefront of development. Other techniques for fabrication have also been used such as inkjet
printing [41]. By creating devices on bendable and stretchable substrates, it is more feasible to
consider this platform for a wearable sensor in the future. Works on mylar are very common as it
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is an extremely thin and transparent film which is a good choice for wearables. Mylar can also
easily be mounted onto PDMS or adhesive tape allowing for a more stretchable design to be
implemented [10], [40]. As a direct result of creating a device on a bendable substrate come
challenges in terms of device inconsistencies upon several mechanical stresses such as bending,
twisting, and stretching. These challenges are where the most recent field of research tends to
focus.
This thesis is novel as it presents a fully printable GFET platform that is implemented as a
wearable device. Currently, this printable platform is one of a kind as it is fabricated using 2D
printed electronics through a PCB printer and silver conductive ink. The GFET is fabricated on a
Dupont™ Kapton® flexible film using a conductive and stretchable silver ink (Dycotec Materials,
Ltd., UK). The device has proven to have sensitive and selective results, can be 2D printed on a
bendable substrate thus reducing cost and production time, and shows positive results under
mechanical stresses. In addition to the advantages that this platform already offers, it can easily be
integrated into wearable electronic devices for sensor input control and data acquisition.
2.3.

GRAPHENE
Graphene has been at the forefront of research since 2004 when graphene was first isolated

by Geim and Novoselov of University of Manchester, UK and has only become increasingly
popular since their research was awarded a Nobel prize in 2010 [71], [72]. Graphene is a twodimensional material of sp2 hybridized carbon atoms in a hexagonal structure [72], [74]. Geim and
Novoselov coined the term ‘Scotch Tape method’ as this was the method used to first discover the
material [72]. As it is only a single atomic layer thick, it comes as no surprise that graphene is the
thinnest material ever discovered [72]. Graphene is referred to as the building block for all
graphitic carbon materials such as carbon nanotubes, graphite, and many others [72]. In addition
7

to being the building blocks of many materials, its carbon makeup also means that it conducts heat
and electricity extremely well [73]. It is also the strongest material ever discovered, while at the
same time the hardest and one of the most pliable [73]. After the ‘Scotch Tape method’ of
discovering graphene, methods such as mechanical cleaving, chemical exfoliation, chemical
synthesis, and thermal chemical vapor deposition were created in order to synthesize graphene
[74].
Often referred to as a “wonder material”, graphene is a one-atom-thick layer of carbon
atoms and is extremely diverse, making its possible applications wide-ranging. Graphene has many
properties that make it advantageous for biosensing such as great conductivity, biocompatibility,
and it is easy to functionalize [44]. Graphene is a versatile material with excellent properties, both
mechanically and electrically, for creating a wearable biosensor. Graphene is made up of carbon
atoms which are bonded tightly through in-plane 6-sigma bonds [26]. The bonds are created in a
hexagonal shape and a network of delocalized electrons in the pi-orbitals are responsible for
graphene being electrically conductive among other features which make it a multipurpose
material [26]. This particular network shape is responsible for the resulting electronic properties
graphene possesses such as a zero-bandgap. Zero-bandgap structure means that at the charge
neutrality point, holes and electrons can seamlessly be converted back and forth [42]. Thus, with
zero-bandgap, the characteristic curve of graphene is continuous and ambipolar as shown in Figure
2.1(B). Figure 2.1(A) shows the VDS applied to the device as well and the VGS. The VGS determines
if current will flow between the source and drain terminals [85]. Figure 2.1(B) displays how the
Fermi energy level relates to the VGS. When the VGS is lower than the Dirac voltage of the device,
the Fermi energy level is in the conduction band and therefore the current is due to hole conduction
[42]. Conversely, when the VGS is greater than the Dirac voltage, the Fermi energy level is in the
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valence band and therefore the current is due to electron conduction. At VGS equal to the Dirac
voltage, the device functions at the intrinsic Fermi level meaning that neither hole conduction nor
electron conduction is dominant. Graphene also has an extremely high intrinsic carrier mobility
and high conductivity which make it ideal for a conduction channel [2]. Graphene allows for the
development of sensors with unprecedented sensitivity, fewer molecular defects, and superior
conductivity [3]. Graphene-based electronics and FETs have proven to have high stability and
electron mobility all while being relatively low cost to fabricate, thus making it highly in-demand
for new electronics and sensors. A further, more extensive review of graphene’s electrical
properties is done in [43].

Figure 2.1: (A) Schematic of GFET device on an SiO2 coated Si substrate (back-gated); (B) Zerobandgap structure of graphene resulting in an ambipolar characteristic curve. Reproduced from
[42].
In addition to a slew of valuable electrical properties, graphene also exhibits tremendous
mechanical properties for creating a wearable biosensor. Graphene is one single atomic layer of
graphite and therefore is a 2D, not 3D material. Graphene is the thinnest and strongest material
ever discovered with an ultimate tensile strength of 130 gigapascals which is over 300 times
stronger than structural steel [3]. Graphene is one atomic layer thick and therefore has unmatched
mechanical flexibility along with optical transmittance [37], [38]. Graphene is the thinnest known
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material which results in an extremely low bending stiffness as bending stiffness is proportional
to the thickness cubed [57]. In addition to its two-dimensional structure being advantageous in
terms of flexibility, it also lends itself to being extremely light weight at only 0.77 milligrams per
square meter [3]. Graphene also has a Young’s modulus of about 0.5 to 1 TPa, spring constant of
about 1-5 N/M, and high material elasticity [2]. With such diverse electrical and mechanical
properties, graphene is highly attractive for creating a biosensor.
2.4.

GRAPHENE-BASED FIELD-EFFECT TRANSISOR
Field-effect transistors (FETs) are devices which utilize a source, gate, and drain terminal

and use a conduction channel and electric field to control the flow of current in a device [28]. In
graphene-based field-effect transistors (GFETs), graphene is used as the semimetal in the
conduction channel. Graphene is a semimetal as opposed to a semiconductor because a semimetal
is defined as a zero-bandgap semiconductor [86]. GFETs are considered an emerging technology
in sensing applications because when a charged molecule adsorbs onto the graphene surface, it
causes a change in the electric field which in turn causes a change in the gate potential of the device
[42]. As a result, this causes a direct change in the channel conductance and subsequent change in
the drain-source current [42]. This concept can be utilized to implement a sensor in which drainsource current changes proportionally to the amount of a particular molecule that is introduced and
thus creating a GFET-based biosensor.
For a GFET, the conductive channel is created using graphene which is in contact with the
drain and source electrodes, all of which is on an insulated substrate. The channel is then modified
using a bioreceptor or specific modifier so that when the target proteins are introduced, the charge
carriers in the conductive channel will be modulated due to the change in the electric field. An
ionic buffer solution is then dropped onto the conductive graphene channel. When a gate-to-source
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voltage (VGS) is applied to the device, the electrical double layer (EDL) forms between the
graphene channel and buffer solution [12]. The electrical double layer results in charges in the
channel as well as a high gate capacitance which causes the electrostatic gating effect [42]. By
altering the channel with outside biomolecules, there will be a change in the transfer characteristic
curve, i.e., the drain-to-source current (IDS) as a function of the gate-to-source voltage (VGS) [29].
The transfer characteristic curve equation is given as follows [67]:
IDS =µ
Where µ is the carrier mobility,

!
"

!
"

Ctot VD (VG-Vth)

is the width to length ratio of the graphene conduction channel,

and Ctot is the total gate capacitance of the dielectric. The gate capacitance is the total of the
capacitance from the electrical double layer [68] as well as the quantum capacitance of the
graphene [69]. VD is the drain voltage, VG is the gate voltage, and Vth is the threshold voltage. 1pyrenebutyric acid N-hydroxy succinimide ester (PBASE) linkers are used to functionalize the
graphene by permanently bonding to the surface through p- stacking and allow for other modifiers,
such as aptamers, to be added which can interact with proteins [16]. Aptamer-based sensing is
highly effective as aptamers have high affinity and selectivity for their targets [30]. Aptamers have
proven to be successful in biosensing as they can bind to a variety of targets including proteins,
peptides and amino acids [30]. Aptamers are immobilized onto the PBASE linkers and a droplet
of liquid buffer is then placed across the drain, source, and gate electrodes. This electrolyte buffer
is the medium through which the gate voltage is applied, thus this type of device architecture is
called a liquid-gated GFET device. When the proteins are introduced to the system, they begin to
interact with the aptamers. As the aptamers bind with the proteins, the aptamers are expected to
undergo a significant conformation change [30]. Due to the changing shape of the aptamers and
the proteins folding, there are measurable changes in IDS which can be used as the sensor’s readout.
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2.5.

INTERLEUKIN-6
Interleukin-6 (IL-6) is a pleotropic cytokine that is produced in response to a plethora of

processes including tissue damage, infections, cancer, and auto immune diseases [11], [45].
Interleukin-6 is also a biomarker for ailments such as collagen vascular disease, alcoholic cirrhosis,
and kidney disease [19]. IL-6 is a protein which can be produced by both normal and harmful
biological process. For instance, it is produced by the body during infections and kidney disease,
but it is also produced by normal cell types that are involved in processes such as reproduction,
metabolism, neural development, bone remodeling, and angiogenesis [46], [47]. Interleukin-6 is
an important protein to sense and monitor as increased levels of IL-6 can require medical attention
for many of the issues and illnesses listed above. Early detection of any one of these diseases or
illnesses is key as it opens up the door for many more options during treatment.
Elevated levels of IL-6 have been linked to the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Contracting SARS-CoV-2 has proven to release a “cytokine storm”
of hyper-inflammatory responses and causes the release of not only Interleukin-6, but Interleukin1, Interleukin-8 and tumor necrosis factor alpha (TNF-a) [21]. Interleukin-6 levels are proven to
increase with respect to disease stage for SARS-CoV-2 and directly relate to respiratory failure
[21]. Furthermore, identification of IL-6 levels allowed for early identification of survivors versus
non-survivors [21]. Additionally, IL-6 levels have proven to be lower for patients with SARSCoV-2 who were in stage IIb and would soon recover into stage IIa in comparison with those who
were in stage IIb and would progress further into stage III [21]. Moreover, the levels of Interleukin6 in the body not only provide important information about the current state of an illness, but also
the likely course that the illness or disease will take next.
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IL-6 is a pro-inflammatory cytokine, meaning it is involved in processes where
inflammation is present. Inflammation is a key sign of cancer growth and progression making it
vital to keep track of and manage [11]. In 2014 it was reported that gastric cancer was the fourth
most common cancer, with 951,000 cases and 723,000 resulting deaths [48]. High levels of IL-6
have been proven to lower the overall survival rate in patients with gastrointestinal (GI) cancer
[11]. Studies have also proven that IL-6 can be used to estimate a patient’s chance of recovery,
reoccurrence of the disease, as well as a patient’s response to therapy [49], [50]. By identifying
and tracking levels of IL-6 early on in a patient’s diagnosis, it can allow both doctor and patient to
have a deeper understanding of the disease stage, future course of the disease, appropriate therapy
and treatments, and much more. Early diagnosis and treatment can be critical for many patients
regardless of ailment. Metastatic dissemination is the main process during the growth of a human
cancer tumor and is the main cause of death from cancer [51]. Early diagnosis allows for local
control, less invasive surgeries, and reduced the need for chemotherapy [51]. Diagnosing a disease
or cancer early also results in less time for a tumor to grow and therefore, at initial treatment there
are more options [51]. Quantification of IL-6 levels is extremely important for disease control and
survival.
2.6.

SENSING CONCEPTS
This section discusses specific terminology and concepts that are critical to understanding

the goals of the project. These terms and concepts specifically relate to graphene-based field-effect
transistors and their applications in the field of wearable sensors, such as liquid gate, aptamers,
Debye length, and Dirac voltage. This chapter gives an overview of GFET operation and explains
the basics of sensing including a brief introduction to the Hill-Langmuir equation.
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2.6.1. LIQUID-GATED FET
In the application of a wearable biosensor, using a liquid-gated FET is extremely practical.
As briefly mentioned in Section 2.5, a liquid-gated FET uses a droplet of a conducting liquid in
the sensing channel to apply the gate-source voltage to the device. Therefore, a liquid gate is very
convenient in a wearable application, as body fluid such as sweat can easily be used as the liquid
across the drain and source where the gate voltage is applied. By using sweat as the means of
sensing, a non-invasive biosensor can be created, thus allowing for a more comfortable while still
accurate biomonitoring device. In addition to the ease of using a liquid-gated device in the
wearable application, in aptamer-based sensing techniques liquid-gating is necessary. The device
used in this research is a top-liquid-gated GFET meaning that the gate voltage will be applied from
the ‘top’ of the channel to the liquid gate.
2.6.2. APTAMER-BASED SENSING
Aptamer-based sensing is highly advantageous when it comes to biosensors. Aptamers are
single stranded DNA or RNA ligands which can be synthesized to bind selectively to a number of
targets [30], [31]. Aptamers offer many benefits such as high specificity and affinity for the target
[30]. The aptamers can also be synthesized with extremely high reproducibility and purity, and
they display properties ideal for biosensing upon target binding [30]. Most aptamers are selected
using systematic evolution of ligands by exponential enrichment (SELEX) to choose aptamers
from liquid biopsy specimens [35], [52]. The SELEX method always begins by introducing the
desired target to a random library that contains between 1012 and 1016 single-stranded
oligonucleotides [35], [53]. Next, oligonucleotides which bind with the target are separated out
and amplified by PCR in an iterative process, each time becoming more selective to the target [35],
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[53]. Finally, the remaining aptamers can be sequenced and identified [53]. This iterative process
is outlined pictorially in Figure 2.2 below.

Figure 2.2: Iterative SELEX method and process of aptamer selection. Reproduced from [53].
When aptamers and targets bind together, the aptamer’s physical structure changes
significantly as it folds in on the protein [30], [32]. With this being said, the aptamer’s new shape
causes a measurable change in the charge carrier concentration in the conductive channel [10].
This change in charge carrier concentration is detected by the device as a change in the IDS.
Aptamers are highly selective to their designated target, meaning that their interactions are
extremely limited outside of such target. The aptamers bind with high specificity as they fold into
secondary and tertiary structures during target interactions [35]. Even extremely small changes in
the target molecule can result in a lack of aptamer binding [30], [33]-[34]. This is a beneficial trait
for a receptor when creating a biosensor as only the selected target should be able to interact with
the aptamer and cause a change in the aptamer structure. Aptamers also allow for extremely
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sensitive devices with dissociation constants (Kd) in the nanomolar to picomolar range [30], [33].
Aptamer-based sensors or “aptasensors” [35], are advantageous and have many benefits over using
antibodies. Aptamers are more stable than antibodies as they are more robust in extreme conditions
such as high temperature or harsh pH levels [35]. Also, it is possible to create aptamers that can
target any molecule from a small molecule to a protein to an entire cell [31], [35], which is not the
case for antibodies. Lastly, aptamers are more adaptable to changes due to their more simple
chemical structures [35].
2.6.3. FUNCTIONALIZATION
Although graphene itself has not proven to be able to directly sense proteins or create links
with aptamers through covalent bonding, it has shown that its p bonds have a willingness to interact
through adsorption of other materials by way of p-p, p-H, p-cation, p-anion, and p-metal
interactions [26]. Functionalization of the nano sensor includes the incubation of PBASE and
aptamers onto the graphene surface. Single stranded probe DNAs (pDNAs) are linked to the
graphene surface via the bifunctional linker 1-pyrenebutyric acid N-hydroxy succinimide ester
(PBASE). PBASE and graphene form strong connections through p- stacking [16]. After
immobilization of the PBASE, the aptamers can then be attached. The aptamers are introduced to
the PBASE and allowed to incubate. During incubation, the aptamers and the PBASE covalently
link together via N-hydroxy succinimide (NHS) crosslinking [20].
2.6.4. DEBYE LENGTH
Debye length is the distance in a semiconductor over which the local electric field
influences the distribution of free charge carriers [28]. The Debye length plays an integral role in
the fundamentals of the graphene-based field-effect transistor and biosensors in general. The
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Debye length describes how far away from the conducting channel of a device the surface charge
density can be affected [28]. The Debye length is important to understand because it is necessary
that the aptamer and protein binding is occurring within the Debye length of the device. Thus, if
the length of the aptamer is too long, the binding process between the target protein and the aptamer
will not occur inside of the Debye screening length, and therefore will not have an effect on the
surface charge density in the conduction channel. The Debye length is identified as one of the
leading issues facing biosensors and FET-based devices [28]. For an electrolyte buffer solution,
the Debye screening length is as follows [39]:
𝑘# $% = '

∈ 𝑘𝑇
𝑒 & ∑' 𝑍' & 𝑛' (

where k and T are the Boltzmann’s constant and temperature respectively, e is the charge of a
proton, ∈ is the permittivity of the solvent, Zi is the charge concentration of ion species i and niB
is the bulk concentration of ion species of i, extending the sum over all ions in the solution [39].
2.6.5. DIRAC VOLTAGE
Graphene-based field-effect transistors exhibit ambipolar behavior meaning that both
electrons and holes can be the majority charge carrier depending on the gate-to-source voltage for
the device. Resultingly, the current-voltage characteristics of a GFET device are V-shaped with a
clear location in which the number of electrons and holes are even, known as the charge neutrality
point or Dirac Voltage. This is detailed in Figure 2.3 below where two transfer characteristic curves
are shown: one before target binding and the other after target binding.
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Figure 2.3: V-shaped transfer characteristic curve (ID vs VGS) with Dirac voltage before and after
target binding.
The left branch of the transfer characteristic curve is when the density of holes is increasing, and
the right branch of the characteristic curve is when the density of electrons is increasing [77]. The
point where the charge neutrality is even corresponds to the minimum drain-to-source current and
the gate voltage that corresponding to the minimum current, is referred to as the Dirac Voltage
[78]. The Dirac voltage is important as it is where the shifts in transfer characteristic curve are
measured about. As different concentrations of target analyte are introduced to a device, the Dirac
voltage should shift to the left or right depending on the charge of the target. This movement in
transfer characteristic curve should be proportional to the concentration of the target that was
introduced. The change in Dirac voltage versus concentration of the target analyte should follow
the Hill-Langmuir equation. The Hill-Langmuir equation describes the relationship between the
concentration of a target analyte and the number of receptors, or in this case aptamers, that have
bound to a target [22]. The Hill-Langmuir equation is used as a benchmark to describe the rate at
which ligands will bind with receptors and is outlined as follows [22]:
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𝐴 = Maximum response with all binding sites occupied
c = Concentration of all the applied target
𝐾) = Apparent dissociation constant that produces half occupation of receptors
n = Hill coefficient
Z = Parameter offset
2.6.6. SENSING MECHANISMS
There are two different sensing mechanisms which have a direct impact on the Dirac
voltage and how it shifts. These two mechanisms are the electrostatic gating effect and the charge
transfer doping effect. While both are similar, one causes positively charged biomolecules to shift
the Dirac voltage in the positive direction while the other causes positive charges to create a shift
in the negative direction, and opposite for negative charges in both cases. The overall resulting
behavior is a combination of these two processes and therefore the more dominant process will
ultimately decide how positive and negative charges influence the Dirac voltage.

Figure 2.4: (A) Schematic of electrolyte liquid-gated GFET (top-gated); (B) Electrostatic gating
effect demonstrated with capacitors formed at the graphene-solution and gate-solution interfaces.
Reproduced from [42].
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The electrostatic gating effect is when the concentration of the adsorbed charged molecules
is so high that the intermolecular distance is less than the Debye length [42]. Subsequently, the
adsorbed molecules act as one of the two plates of the electrical double layer (EDL) formed on the
graphene-electrolyte interface as shown in Figure 2.4(B). Therefore, any additional charged
molecules which are adsorbed onto the graphene will modulate this charge density in the EDLs
resulting in a change in the channel current [42]. Therefore, if the adsorbed molecules are
positively charged, the Dirac voltage will shift in the negative direction and result in having to
apply a voltage that is less positive to compensate for the additional charge stored in the EDL [42],
[75], [76]. In a similar way, if the molecules that are adsorbed into the graphene are negatively
charged, the resulting Dirac voltage will shift in the positive direction and therefore a more positive
charge will need to be applied due to the negative charges in the EDL [42], [75], [76].

Figure 2.5: Charge transfer doping effect demonstrated in GFET. Reproduced from [42].
The charge transfer doping effect is a result of direct charge transfer from the adsorbed
molecules to the graphene surface [42]. This happens specifically when the biomolecules
introduced are at low concentration or are weakly charged as detailed in Figure 2.5 [42]. This
causes the adsorption density to be small and therefore the distance between the adsorbed
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molecules is larger than the Debye length of the channel [42]. Furthermore, the charge transfer is
then dominant between the adsorbed molecules and the channel itself [42]. Therefore, if adsorbed
molecules are positively charged, the Dirac point will shift in the positive direction or if negative
charges are introduced the Dirac voltage will shift in the negative direction [42], [75].
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CHAPTER 3: MATERIALS AND METHODS
3.1.

OVERVIEW
This chapter discusses in-depth the device fabrication procedure for creating the printable

and flexible graphene-based field-effect transistor (GFET) platform. This chapter also includes an
overview of how KiCAD is used to create the design, using the Voltera V-One PCB printer to print
the design, and easy transfer graphene which is used as the conductive channel between the source
and drain electrodes. Reliability throughout the fabrication process is also discussed. This chapter
includes all necessary steps and procedures to fabricate the GFET.
3.2.

DEVICE FABRICATION

3.2.1. KICAD
The fabrication process of the wearable GFET begins with the initial design that is created
using KiCAD which is an open-source computer aided design software. The KiCAD schematic
includes the layout for all drain, source, and gate electrodes. The KiCAD software allows for
variation in trace width, layer, shape, and a variety of other tools. The final design features six
drain/source electrodes and one gate electrode as shown in Figure 3.1. Table 3.1 details the layout
of the GFET design specifically which electrodes are the drain, source, and gate for each of the
five GFET devices created in the pattern.
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Figure 3.1: Final KiCAD design featuring 7 electrodes; electrodes 1 – 6 as drain/source and
electrode 7 as gate with line width 350µm and line spacing 250µm edge to edge.
Trace width and trace spacing were two factors that were critical to optimize for the printable
device. It is important to balance these two elements as the smallest feature size possible is needed
while also keeping the widest possible electrode in order to reduce the trace resistance. Upon
completion of the KiCAD design, multiple files are generated with each of the different printing
layers, which can then be uploaded into the Voltera software for the next fabrication step.
Table 3.1: Summary of labels for final GFET device.
Device #

Source/Drain electrode

Gate

GFET-1

1/2

7

GFET-2

2/3

7

GFET-3

3/4

7

GFET-4

4/5

7

GFET-5

5/6

7
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3.2.2. VOLTERA V-ONE PCB PRINTER
The goal during fabrication of the GFET biosensor was to create a low cost, time effective and
adaptable procedure that would allow for easy replication and production of many devices. Most
often in fabrication of microdevices and biosensors, techniques such as lithography, etching, and
liftoff are used [1], [6], [40]. These procedures are quite costly and can take a large amount of time
to carry out. It can also be quite a rigid process as in order to change even the smallest of
characteristics requires a lot of work, for example creating a new mask each time a minor change
needs to be made. In this application, to fabricate the electrodes for the GFET, a Voltera
(Kitchener, Canada) V-One PCB printer was used. The Voltera V-One PCB printer, shown in
Figure 3.2, is a multi-functional circuit printer that is especially good for higher viscosity inks and
can print on a wide variety of substrates.

Figure 3.2: Voltera V-One PCB printer used for rapid fabrication of GFET electrodes.
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The printer allows the user to upload a CAD file and then simply prints the CAD file pattern
onto the substrate of the user’s choice. Moreover, this results in an extremely fast and adaptive
process as changes to features such as line width, substrate, ink or even large changes to the design
can be swapped in seconds and reflected to the device during printing within minutes. The Voltera
V-One printer prints patterns extremely quickly. Although the printing time is directly proportional
to the size of the design, number of lines and shaped to be printed, most designs are printed in
under 3 minutes with the whole printing process taking a total of about 25 minutes, including 15
minutes for heating to dry the ink. The Voltera allows for the user to control a variety of settings
and printing conditions such as printing speed, height, flow rate and many others as shown in
Figure 3.3. Such flexibility in printing conditions does create room for human error and therefore
a KiCAD pattern that can be implemented to the Voltera without concern of electrode shorts and
design issues must be created.

Figure 3.3: Voltera V-One printer settings options.
3.2.3. PRINTING RELIABILITY
As mentioned previously, ensuring that the feature size of the device is as small as possible
is extremely important while also maximizing the width of the traces. In order to ensure reliable
printing where none of the electrodes short together during the printing process, a variety of both
25

trace width and trace distance are assessed. Table 3.2 below shows the combinations of electrode
widths and distances, measured from edge to edge, that were tested. All design specifications were
printed using the Voltera V-One, utilizing the 100-micron nozzle heads and standard printing
conditions specified from Voltera. While the first few options were not viable as the Voltera VOne could not print this close consistently without the electrodes shorting together, the distances
above 250 µm proved to work well. After analysis, a 350 µm electrode width with an electrode
distance of 250 µm gave the most consistent results with the largest electrode width yet smallest
distance between electrodes.
Table 3.2: Electrode widths and distances tested in KiCAD design and printed with Voltera.
Electrode Width
(µm)

Electrode Distance
(µm)
(edge to edge)
100
100
100
150
150
150
250
250
250
500
250
700
*350
*250
350
500
450
500
*Final design parameters

Once the design is finalized and printed, the substrate is heated at 100 degrees Celsius for 15
minutes in order for the ink to cure. At this point the initial design is completed and the electrodes
are ready for graphene.
3.2.4. EASY TRANSFER GRAPHENE
A field-effect transistor needs a conducting material placed between the drain and source
electrodes in order to function. A GFET utilizes a graphene film to create this channel. Graphene
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transfer is done using chemical vapor deposition (CVD)-grown graphene from Graphenea Inc.
(San Sebastián, Spain). These graphene sheets are known as easy transfer monolayer graphene
which are created on a polymer film and covered with a sacrificial layer as shown below in Figure
3.4 [23].

Figure 3.4: 1 cm × 1 cm easy transfer monolayer graphene from Graphenea on a polymer film.
A unique fishing technique is employed in order to ensure a higher success rate in placing the
graphene more precisely across the drain and source electrodes. The traditional fishing method
consists of placing the sacrificial layer/graphene/polymer substrate onto the surface of deionized
water slowly. The backing is then slowly peeled away using tweezers, leaving just the sacrificial
layer/graphene. Finally, using the substrate below the water, catch the sacrificial layer/graphene
perfectly across the electrodes. This entire process is outlined in Figure 3.5, courtesy of Graphenea.
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Figure 3.5: Graphene transfer process using fishing technique. Reproduced from [5].
This method was slightly modified to increase consistency when placing the graphene across the
electrodes. Instead of taking the bulky substrate and placing it under the graphene and trying to
quickly lift and catch the graphene, a modified process was used. By using a pipette and placing
approximately enough deionized water to cover the device on the substrate, this removes a large
amount of uncertainty of where the graphene will land. The sacrificial layer/graphene/polymer
substrate are then placed into this much smaller droplet and the polymer substrate is then slowly
removed. Next, the water is slowly removed using the pipette and along the way the sacrificial
layer/graphene is directed until it is in the desired location. Once the sacrificial layer/graphene are
across the electrodes, the device is allowed to air dry for one hour and then heated at 250 °C for
one hour. After the heating process, the sacrificial layer is then removed by submerging the
sacrificial layer/graphene/new substrate in acetone for one hour, ethanol for one hour, and
deionized water for one hour. After completing all fabrication steps including design, printing, and
graphene transfer shown in Figure 3.6(A), the device will look as shown in Figure 3.6(B).
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Figure 3.6: (A) Fabrication steps for the GFET device; (B)Voltera V-ONE printed graphene-based
FET on Si/SiO2 wafer using KiCAD design. Easy transfer monolayer graphene transferred across
drain and source electrodes.
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CHAPTER 4: CHARACTERIZING GFET
4.1.

OVERVIEW
This chapter discusses the process of finalizing all parameters of the GFET biosensor

design. A characterization of multiple substrates choices is presented as well as a comparison of
multiple inks that can be used in conjunction with the Voltera V-One printer. After finalization of
the design parameters, this chapter also presents the methods of preparing the device for
biosensing. Preparation includes functionalization of the graphene surface and immobilization of
aptamers on the graphene as well.
4.2.

REQUIRED MATERIALS
For GFET characterization and sensing the following materials are needed:

•

0.01 × PBS buffer: 200 𝜇L of 10 × PBS is combined with 199.8 mL of deionized water.

This ratio is used as 0.01 × PBS has a Debye length of approximately 7.3 nm [23].
•

PBASE in DMF: 10 mM solution of PBASE in DMF is created in order to functionalize

the graphene. PBASE was purchased from Santa Cruz Biotechnology (TX, USA).
•

Aminated aptamers: Aptamers with specific affinity to mouse IL-6 (#ATW0077, KD = 5.4

nM) were purchased from Basepair Biotechnologies, Inc. (TX, USA). The aptamers were prepared
following the Basepair Biotechnologies, Inc. best practices: Handling and Storage information and
therefore used amine resuspension buffer and the 0.01 × PBS +1 mM MgCl2 solution. 1 mM
MgCl2 is used in order to help the aptamers bind properly as changes in magnesium chloride have
been proven to have an effect on binding affinity [23]. This solution is created using 10 𝜇L of 10
× PBS, 9.99 mL of deionized water and finally 1 g of MgCl2.
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•

Interleukin-6 recombinant mouse protein: IL-6 protein was purchased from BioLegend®

(San Diego, CA) and prepared into five different concentrations. The IL-6 protein is 34 𝜇M as
packaged and concentrations of 100 nM, 10 nM, 1 nM, 100 pM, and 10 pM were prepared using
0.01 × PBS.
4.3.

SILICON OXIDE COATING
Silicon oxide coating has proven to enhance the sensing performances of GFET devices.

Naturally occurring organic contaminants can cause issues with sensor sensitivity, decreased
carrier mobility and unwanted doping of the substrate [6]. By using an SiO2 coating on the
substrate, it helps prevent many of these issues by improving the substrate surface. First of all, the
coating provides protection for the graphene against unwanted doping and also provides a
smoother surface for the device which allows for a higher quality fabrication of the GFET device
[6]. Secondly, the coating has also been proven to have tremendous impacts on the
transconductance of the device which is directly related to the sensor sensitivity. Lastly, the silicon
oxide coating provides more consistency in the overall sensor performance. Zhuang et al.
exemplify how the silicon oxide coating creates not only a more consistent IV characteristic curve
for their device, but it also creates sharper edges and therefore higher transconductance near the
Dirac voltage [6]. This is extremely beneficial as during the real-time sensing, the sharper these
curves are, the more change will be observed in the current with relation to time. The device
consistency, transconductance, and surface morphology results are summarized in Figure 4.1.
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Figure 4.1: SiO2 coating impacts on (a) device transfer characteristic curve; (b) device
transconductance in both the hole and electron branches; (c,d) surface morphology of bare
substrate and 50 nm SiO2 coated substrate. Reproduced from [6] with permission from the Royal
Society of Chemistry.
While finalizing the design features and parameters of the flexible biosensor, an SiO2 coating on
multiple substrate options was investigated. A 50 nm SiO2 coating was deposited onto the bare
Kapton film (12 inches × 12 inches × 1 mil) using a sputter deposition system from the
Nanofabrication Laboratory at the University of Massachusetts Lowell. The goal here is to ensure
that the SiO2 coating has the same impact, specifically on the transfer characteristic curve, as
outlined above in Figure 4.1. In order to ensure the reliability of the results, the effect of a 50 nm
SiO2 coating was explored on the Kapton film.
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Figure 4.2: Transfer characteristic curve of GFET device fabricated on (a) Kapton substrate with
50 nm SiO2 coating versus bare Kapton film; (b) SiO2 coating provides consistency to transfer
characteristic curve measurements.
Consistent with the results from the Lin et al. research paper, the SiO2 coating proves to produce
a significantly steeper transfer characteristic curve [6]. Figure 4.2(A) shows that the silicon oxide
coating improves the device characteristics. In Figure 4.2(A) the bare Kapton curve reaches a
maximum normalized current of about 7 µA while the SiO2 coated Kapton reaches a normalized
current of about 50 µA, thus vastly improving the conductivity of the device. In Figure 4.2(B) the
device consistency is displayed. The SiO2 coated Kapton GFETs (k-GFETs) display more
consistent results device to device on the same substrate in comparison to devices fabricated on
the bare Kapton film.
4.4.

SUBSTRATE SELECTION
A wearable biosensor must be accommodating to the human body and thus needs to be

able to be integrated in a wearable and flexible platform. Substrate choice is key as it will ensure
the safety and subsequently the effectiveness of the biosensor. Substrates such as biaxially-oriented
polyethylene terephthalate (Bo PET) also known as Mylar, polyamide film named Kapton by
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DuPont, and polydimethylsiloxane (PDMS) are all substrates that could accommodate the needs
of the device.

Figure 4.3: Flexible film substrates (A) Kapton substrate; and (B) Mylar substrate.
Kapton is a polyimide film which is lightweight and bendable, shown in Figure 4.3(A).
The Kapton film used in this application was 0.001 inches thick which is about 25 µm. The mylar
film being used was 2.5 µm and therefore about 10 times thinner. The Kapton was able to provide
more structure and its rigidity helped prevent potential tears while still offering an extremely
bendable device. Kapton has an extremely high melting point and thus can withstand extreme heat
up to 400 ºC [18]. Mylar is a polyester film that is extremely thin and lightweight and conforms
well to the skin, thus giving it potential as the substrate for a wearable device (Figure 4.3(B)).
Mylar is a transparent film that is commercially available for purchase at a thickness of 2.5 µm
[10], [58]. It offers advantages such as a high tensile strength, electrical insulation, and stability
[17]. Disadvantages of this film include a tendency to easily crumple and tare thus causing issues
34

for the sensor and a relatively low melting point in comparison to other films at 250 ºC. Another
disadvantage to using a Mylar film is that it frequently requires bonding to a rigid substrate during
fabrication [10]. While both Mylar and Kapton are thin films that present themselves as possible
options for a wearable sensor substrate, there are also silicone materials that could be advantageous
as well.
Silicone rubbers are often used in the creation of microchannels and nanoscale devices as
they are easily implemented for stamping, molding, and the surface properties are easy to modify
[88]. PDMS is widely used as it is low cost, simple to fabricate, thermally stable, resistant to
oxidation, clear and easily pliable as shown in Figure 4.4 [56], [59]. PDMS is a commercially
available two-part silicon-based polymer. It can easily be molded to various shapes, cut, bent, and
even stretched to a degree without compromising the integrity.

Figure 4.4: Polydimethylsiloxane (PDMS) polymer substrate.
The PDMS substrate provides flexibility similar to Mylar and Kapton but also provides more
strength than the two previously mentioned substrates.
35

To select the proper substrate for device fabrication, the KiCAD design was printed onto
each of the three potential substrates which had each been coated with 50 nm of SiO2. A silicon
wafer substrate with the same design was also used during the process as a baseline for comparison.
Graphene was then transferred across each of the four designs and the bare graphene transfer
characteristic curve of each GFET device was measured as shown below in Figure 4.5.

Figure 4.5: Transfer characteristic curve with VDS = 100mV for Si/SiO2 wafer (baseline), SiO2
coated Mylar, SiO2 coated Kapton, and SiO2 coated PDMS.
The Kapton substrate exhibits the sharpest IDS versus VGS characteristic curve, making it
the best option for creating a wearable biosensor moving forward. Mylar displays promising results
as the magnitude of the current is similar to the silicon wafer which was used as a baseline.
Alternatively, the GFET device fabricated on the PDMS substrate displays almost no change in
current flow regardless of the gate-to-source voltage which was applied to the device. This
excludes the PDMS substrate from being a viable option as it will make it extremely difficult to
identify the Dirac voltage for a GFET with a characteristic curve with such a gradual incline.
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4.5.

INK CHOICE
In the ideal case for a wearable, the sensor would be fabricated on a flexible and stretchable

substrate and the device itself would also be able to stretch and bend. In order to understand if a
fully stretchable and bendable device is feasible, a variety of inks were tested on a flexible and
stretchable Eco-Flex silicone rubber substrate. Eco-Flex is a two-part silicone rubber similar to
PDMS. A combination of inks was investigated including Voltera Flex Ink, Dycotec Flexible and
Stretchable ink, and multiple homemade ink mixtures.
A homemade ink mixture is attractive for creating a GFET device as the base material can
be controlled and thus can be used to increase flexibility and stretchability. In this application a
PDMS base was used for the ink with a mixture of carbon nanotubes, carbon nanofibers, and silver
flakes [60-62]. In order to create the ink, the PDMS polymer-base was first mixed with toluene as
this will allow for the conducting particles to be evenly dispersed [62]. The carbon nanotubes,
carbon nanofibers, and silver flakes are then added to the toluene solution which is then placed
into a bath sonicator for 5 minutes to ensure particle dispersion. After dispersion, the solution is
placed onto a hot plate and heated at low temperature (70 ºC) while simultaneously magnetically
stirred until the toluene solution is evaporated [62]. After evaporation, the PDMS curing agent is
added to the mixture and is ready to be used as an ink. While the printable ink is an attractive
option, after numerous attempts with variety in amount of carbon nanotubes, carbon nanofibers
and silver flakes, the ink was never conductive enough to support a current and therefore one of
the two commercially available inks would need to be used moving forward.
The ink stretchability was investigated by printing ten 1 mm wide electrodes onto the EcoFlex substrate. This was done for each of the two commercial inks, as the custom ink was never
able to support a current. After curing, the electrodes were then encapsulated in another thin Eco-
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Flex layer for support. Beginning with the Voltera ink, the 10 electrodes are printed onto the
substrate and the resistance of each electrode is measured and recorded. The KiCAD file for the
stretchability testing is shown in Figure 4.6.

Figure 4.6: KiCAD stretchability file containing ten 1 mm wide traces.
The electrodes are then stretched at increments of 5% in order to better understand the trend of
resistance versus stretching percentage (electrode length). This process is repeated until the
electrode resistances are into the range of megaohms or the electrodes themselves break. The
Voltera ink was highly conductive at 0% stretching and had an average trace resistance of 0.4889
ohms. After being stretched to just 5% of the original electrode length, all of the electrodes had
broken as outlined in Figure 4.7. Although advertised as a flexible ink, even upon extremely small
levels of handling or bending of the substrate, the Voltera ink traces broke.
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Figure 4.7: Dycotec stretchable silver conductive ink versus Voltera Flex silver conductive ink.
Following the same process as above, the Dycotec ink was examined next. During this
analysis, the average resistance was 0.67 ohms at 0% stretching, and 31.8 ohms, 93.1 ohms, and
561.8 ohms at 5%, 10% and 15% respectively as shown in Figure 4.7. Above 15%, although there
was data collected, the error was so large that it is not reliable as it may not be reproducible in the
future. Thus, to continually select the most advantageous parameters for creation of the GFET
biosensor, the device is be printed on Kapton film with a 50 nm SiO2 coating using the Dycotec
silver conductive ink as shown in Figure 4.8.
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Figure 4.8: GFET design with all parameters finalized. Substrate: 50 nm SiO2 coated Kapton; Ink:
Dycotec flexible and stretchable silver conductive ink.

4.6.

MECHANICAL STRESS
Making sure that biosensor operation does not change from basic, rigid implementation to

wearable, bendable implementation is critical. It is only practical that device functionality is stable
over various bending radii as in the GFET biosensor’s true application, mechanical stresses on the
substrate are unavoidable. GFET sensors have been proven to be able to withstand a wide range
of mechanical stresses including bending [6], [10], [55], stretching [40], twisting, and a
combination of all at once [10]. In order to understand the appropriate range of substrate bending
that the GFET can withstand and should be used in, the Kapton substrate was characterized at
different bending radii. The procedure for characterization was to begin with the blank device
completely flat to obtain a baseline measurement for the GFET characteristic curve. After this, the
GFET was bent using three different inward bending substrates with radii of 4.25 cm, 2.25 cm and
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1.5 cm respectively. The GFET transfer characteristic curves were then measured once again to
observe the Dirac voltage and potential shift. This process was repeated for 3 different inward
bending radii as in real applications the device would be facing the skin and therefore the most
likely bending would be an inward bending.

Figure 4.9: (A) Transfer characteristic curve of GFET on flat substrate and bent around radii of
1.5 cm, 2.25 cm, and 4.25 cm; (B) Change in Dirac voltage with respect to the bending radius of
the substrate. Error bars created with N = 5 devices.
As can be seen in Figure 4.9(A), the inward bending of the substrate did cause variation in the
transfer characteristic curve. Figure 4.9(B) shows the change in Dirac voltage with respect to the
bending radii of the device. The error bars are created with five devices. While all bending radii
show a very small shift in Dirac voltage, the 2.25 cm bending radius showed the least amount of
variation in transfer characteristic curve and shift in Dirac voltage. Following this was the smallest
bending radius of 1.5 cm and lastly the most variation was in the largest bending radius of 4.25
cm. A relatively random shifting in Dirac voltage with respect to bending radius is consistent with
previous works [6]. A small change in Dirac voltage is consistent with other findings as well [6].
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The results obtained from these analyses suggest that the biosensor can operate properly in all of
the bending conditions observed in this work.
4.7.

GFET FUNCTIONALIZATION
In order to prepare the graphene FET to be used as a biosensor, the target molecules need

to interact with the GFET and influence the charge carriers in the conduction channel of the
transistor. The first step of the functionalization process is to add PBASE to the graphene surface.
PBASE is essential to the GFET device functioning properly as this linker allows for aptamers to
attach to the graphene surface and therefore targets will directly be able to influence the device
drain-source current.
Functionalization of the device is done by placing a 200 µL droplet of 10 mM PBASE in
dimethyl formamide (DMF) onto the graphene surface at room temperature for 2 hours. The device
is prepared for functionalization by mounting an Eco-Flex well (1 cm × 0.5 cm × 0.5 cm) across
the drain and source electrodes to keep the PBASE solution on the graphene surface, as DMF is
extremely volatile and could interfere with the bare silver electrodes. After the PBASE in DMF
has incubated for two hours, the substrate is then washed successively with DMF, ethanol, and
deionized water for 3 minutes each. This ensures that there are no loose PBASE linkers still on the
substrate. Immobilization of the PBASE linker onto the graphene surface causes a p-type doping
effect to the graphene and will cause the transfer characteristic curve and Dirac voltage to shift to
the right due to the transfer of charges between the PBASE and graphene [63], [64]. The carbonyl
group of PBASE is an electron-withdrawing group which means it can cause electron transfer to
occur from the graphene to the linker, which is why there is a positive shift in Dirac voltage [65].
The last step in the GFET functionalization is the immobilization of the aptamers. The aptamers
used during sensing are synthesized from BasePair Biotechnologies, Inc (TX,USA). The aptamer
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target for selection is recombinant mouse Interleukin-6 (IL-6). The aptamers are single stranded
DNAs with a length of 32 nucleotides and an average KD of 5.4 nM [36]. Aminated (5’) pDNA at
5 µM in 0.01 × PBS+1 mM MgCl2 are introduced to the graphene in the form of a 100 µL droplet
again at room temperature for two hours. After incubation, the excess aptamer solution is then
rinsed with 0.01 × PBS in order to remove all leftover aptamers. Immobilization of the aptamers
causes in a left shift because of n-type doping which results due to negatively charged DNA strands
serving as electron donors when they interact with the graphene surface [65]. A positive shift due
to PBASE attachment and a negative shift from aptamer immobilization is consistent with results
from [6], [65], [82]. These results are summarized below in Figure 4.10. With the aptamers
securely linked via PBASE to the graphene surface, the GFET can be used as a nano sensor.

Figure 4.10: Transfer characteristic curves during functionalization displaying p-type doping after
introduction of PBASE and n-type doping after introduction of aptamers.
The immobilization of aptamers onto the graphene surface is critical in order for the
graphene-based FET to operate as a biosensor. Without the aptamers and PBASE linkers attached
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to the graphene surface, the IL-6 proteins do not bind with the graphene surface. Without this
binding there will be no shift in the drain current with respect to the gate-to-source voltage and
therefore the concept which is being employed here will not hold. Figure 4.11 demonstrates the
importance of using the aptamers and the linkers to achieve selective sensing on a graphene-based
platform. Without the linkers and the aptamers present, there is practically zero change between
the bare graphene characteristic curve and the five subsequent concentrations of Interleukin-6 that
were introduced. The error bars in Figure 4.11(B) are generated with N = 6 devices and they
represent one standard error. This indicates that without the incorporation of the linkers and targetbinding aptamers; the target proteins are not able to directly influence the graphene conducting
channel.

Figure 4.11: IL-6 sensing process performed on Kapton GFET without PBASE and aptamers. (A)
GFET transfer characteristic curves with VDS = 50 mV; (B) The corresponding calibration curve.
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CHAPTER 5: DETECTING BIOMARKER
5.1.

OVERVIEW
This chapter details the process of detecting Interleukin-6 (IL-6) using the printable

graphene FET biosensor. Two different detection modes were implemented, namely the static
voltage sweep method and continuous real-time sensing. The static method of sensing has multiple
variations and thus both are discussed. Furthermore, the selectivity of the sensor is discussed along
with the limit of detection. The impacts of mechanical stress on the substrate were also
characterized during the sensing process in order to ensure consistency across all conditions.
5.2.

SENSING THEORY
The goal of the graphene transistor-based biosensor is to characterize the relationship

between the concentration of the target analyte IL-6 and the resulting change in Dirac voltage. The
conceptual illustration shown below in Figure 5.1 outlines the working principle of the device.

Figure 5.1: Conceptual drawing detailing how protein introduction impacts the sensor behavior,
specifically the transfer characteristic curve and resulting Dirac voltage.
The rationale for developing this platform is that the flexible, Kapton-based GFET will be mounted
on the user’s skin and sweat will be used as the liquid gate for the device, thus creating a non45

invasive way to monitor the user’s health conditions. It is anticipated that with different
concentrations of target analyte being introduced to the system, multiple different characteristic
curves would be generated and thus a change in Dirac voltage that is proportional to the
concentration of the analyte would be observed. Finally, instead of sweeping the gate-to-source
voltage, which is not feasible for real-time monitoring of the target biomarkers, the gate-to-source
voltage will be fixed. By fixing the gate-source voltage, a user can simply monitor changes in the
drain-to-source current over time. Therefore, any changes seen in the current are directly related
to changes in the target concentration.
5.3.

STATIC SENSING
Static sensing is the process of measuring the transfer characteristic curve (IDS versus VGS),

of the GFET device for various IL-6 concentrations. The name ‘static sensing’ is given because
during this mode of measurement, the protein is introduced in a droplet form and thus is not moving
across the channel as in real-time sensing. This is different from real-time sensing because in this
sensing mode it is not possible to monitor the change in the concentration continuously in realtime and gain time-dependent information from the results. The first step in static sensing is to get
a baseline measurement of the GFET characteristic curve with no target analyte. This is done after
PBASE functionalization and aptamer immobilization. A 180 µL droplet of 0.01 × PBS buffer is
dropped onto the channel and the characteristic curve is then measured. This measurement is the
standard for where the change in Dirac voltage will be measured from. The buffer solution is
removed from the GFET channel and multiple concentrations of protein are then introduced one
at a time. Beginning with 10 pM, the analyte solution is dropped in a 180 µL droplet onto the
device and incubates for ten minutes to allow the aptamers and proteins to bind together. The
analyte solution is then removed and replaced with the 0.01 × PBS buffer and the GFET transfer
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characteristic curve is then measured. The graphene surface is then rinsed with 0.01 × PBS buffer
and the next concentration, 100 pM, is then introduced. Five different concentrations of IL-6 will
be introduced to the substrate one at a time. After each incubation, the graphene surface is washed
with the buffer and the transfer characteristics are measured for each of the five devices that make
up the GFET. After measurement, the graphene channel is rinsed using the 0.01 × PBS buffer
solution and the new concentration is then dropped, replacing the old protein, and the process is
repeated. After each of the six transfer characteristic curves are measured, one baseline and five
concentrations, the results are combined into a single normalized graph where the current
corresponding to the Dirac voltage for each curve is set to be zero as shown in Figure 5.2(A).

Figure 5.2: IL-6 static sensing with 0.01 × PBS as liquid gate and VDS =100 mV. (A) Normalized
transfer characteristic curves showing a right shift in Dirac voltage with respect to concentration;
(B) Concentration calibration curve showing the changes in Dirac voltage as a function of
concentration with resulting Hill-Langmuir line of best fit (R2 = 99.27%).
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Table 5.1: Average shift in Dirac voltage for IL-6 static sensing with 0.01 × PBS as liquid gate
and VDS = 100 mV.
Average shift in Dirac voltage (mV)
10 pM
100 pM
1 nM
10 nM
100 nM

24.781250
129.109250
307.383500
356.538500
411.979000

Normalization makes it clear to see how protein concentration and binding impacts the
conduction channel of the device, and specifically the Dirac voltage. Not only is there a shift in
the Dirac voltage but the shift is proportional to the concentration of IL-6 protein that was
introduced to the device which is displayed in Figure 5.2(B). Figure 5.2(B) is obtained by plotting
the change in Dirac voltage from the buffer solution (zero concentration) to the concentration of
interest, which are explicitly stated in Table 5.1. The error bars are generated with N = 4 devices
and they represent one standard error. By simply comparing the change in Dirac voltage as a
function of concentration, ideally the data should follow the Hill-Langmuir equation. When the
data is plotted it is obvious that it closely follows the Hill-Langmuir equation. IL-6 at a pH of 7.4
is used in all sensing applications. At this pH, IL-6 is negatively charged, and as observed
throughout this work, the Dirac voltage shifts to the right. Due to the fact that the PBASE is
introduced at such high concentration during functionalization in conjunction with the positively
shifting Dirac voltage, it can be concluded that in this application the electrostatic gating effect
dominates over the charge transfer doping effect. The results obtained from this method of sensing
strongly suggests that the concepts that are being used can be implemented for wearable
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applications. If the gate-to-source voltage is fixed, it is possible to monitor the drain-to-source
current over time and be able to monitor changes in current instantaneously.
5.3.1. BUFFER LIQUID GATE VS ANALYTE LIQUID GATE
There are multiple approaches for how to conduct static sensing, specifically how the liquid
gate solution influences the shift in Dirac voltage. The first method is to introduce the protein to
the graphene, incubating for 10 minutes, and then rinse the graphene surface briefly as discussed
in Section 5.3. The buffer solution is then dropped onto the graphene and the transfer characteristic
curve is measured. This method is simple and eliminates the influence of proteins that are bound
nonspecifically but dissociation is present. The moment that the protein is removed from the
graphene, it is no longer known if the proteins are attached to the graphene or if dissociation has
begun. It is also possible that proteins were removed either during the rinsing process or end up
free in the buffer solution.
To remove the uncertainty that is brought upon by the rinsing step, the second method is
to apply the protein and, after incubating for 10 minutes, measure the current without rinsing the
graphene surface. This process eliminates the question of proteins being washed away or
dissociating during the measurement process. However, this process does introduce its own issues
to the procedure. By keeping the protein on the device, the issue of nonspecific binding will be
present in the measurements. Furthermore, the protein sitting on the device during the
measurement process will ensure that the Dirac voltage is being influenced by both specifically
and nonspecifically bound proteins. Figure 5.3 shows the results from using the same static sensing
procedure as discussed in Section 5.3 but this time without the rinsing step; therefore, the liquid
gate is the analyte solution. By using the IL-6 solution as the liquid gate, a much larger shift in the
Dirac voltage is observed. This is to be expected because there will always be more proteins
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present and therefore bound to the aptamers on the device when the target analyte is present in
comparison with only a buffer. In Figure 5.3(A) there is a shift of nearly 1 V from 0 pM to 100
nM which is significantly larger than sensing with buffer as the liquid gate. The error bars represent
one standard error and are generated with N = 4 devices.

Figure 5.3: IL-6 static sensing with analyte as liquid gate and VDS = 10 mV. (A) Normalized
transfer characteristic curves showing a right shift in Dirac voltage with respect to concentration;
(B) Concentration calibration curve showing change in Dirac voltage as a function of concentration
with resulting Hill-Langmuir line of best fit (R2 = 98.37%).
N=4
N=4

10 pM
100 pM
1 nM
10 nM
100 nM

Average shift in Dirac
voltage (mV)
Rinsing
No Rinsing
24.781250 530.612250
129.109250 709.168500
307.383500 816.320750
356.538500 995.505250
411.979000 1012.73350

Figure 5.4: (A) IL-6 calibration curve showing change in Dirac voltage as a function of
concentration. The black represents experimental data points where there the graphene is rinsed
before sensing (liquid gate: 0.01 × PBS buffer) and the purple represents experimental data points
where there the graphene is not rinsed before sensing (liquid gate: specified concentration of IL-6
solution); (B) Side by side comparison of rinse (buffer liquid gate) versus no rinse (analyte liquid
gate) shift in Dirac voltage as a function of concentration.
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Figure 5.4(A) makes a clear comparison between the sensing with the target analyte as the liquid
gate and the using a buffer solution as the liquid gate. There is a significantly larger change in
Dirac voltage when the IL-6 protein is present in comparison to when there is only a buffer.
Specifically shown in Figure 5.4(B), the largest change in Dirac voltage for the rinsing case did
not shift as significantly as the smallest change in Dirac voltage for the non-rinsing case.
Furthermore, the change for these two cases were 412 mV and 531 mV respectively. Although
there is a more substantial shift in Dirac voltage when the IL-6 is used as the liquid gate, there is
also much more error introduced to the experiment. The error bars for the 0.01 × PBS buffer liquid
gate are created with N = 4 devices and the error bars for the target analyte liquid gate are created
with N = 5 devices. The error bars are significantly larger for the case when the target analyte is
used which is not desirable. Moreover, there are arguments that could be made in defense for either
one of the two methods presented.
5.3.2. SELECTIVITY AND LIMIT OF DETECTION
The selectivity of a biosensor ensures that the results and data obtained are specific to the
target and not due to other possible interfering species. In this work, aptamers were used to enhance
the selectivity of the device. Aptamers promote selectivity because they exhibit preferential
binding to the target analyte compared to other molecules. This lowers the probability of false
readings due to other biomolecules that could interfere with the GFET device. It is important to
make sure that even the proteins that are similar in physical structure to the target IL-6 biomarker
do not interact with the sensor and cause a shift in the Dirac voltage.
For selectivity testing, the protein tumor necrosis factor alpha (TNF-a) was used. TNF-a
is used in this case because structurally it is very similar to Interleuken-6. As TNF-a and IL-6 are
both cytokines that are actively present during proinflammatory processes, they often appear in
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the body simultaneously which is an example of why selectivity of the device is important. If the
device is exclusively monitoring the levels of IL-6 then the presence (or absence) of other proteins,
specifically TNF-a in this case, should cause no change in the current-voltage characteristics and
therefore no change in the Dirac voltage. As done above in the static sensing of IL-6, five different
concentrations of TNF-a will be introduced one at a time to the device, the current-voltage
characteristics will be recorded, and the Dirac voltage will be identified. By comparing the
calibration curve of the IL-6 measurement with the calibration curve of the TNF-a measurements,
there should be a concentration dependent shift with each IL-6 protein and for TNF-a, ideally there
should be zero shift for all concentrations that are introduced.

Figure 5.5: TNF-a selectivity static sensing with 0.01 × PBS as liquid gate and VDS = 100 mV.
(A) Normalized transfer characteristic curves showing concentration independent change in Dirac
voltage; (B) Calibration curve showing IL-6 change in Dirac voltage as a function of concentration
with resulting Hill-Langmuir line of best fit and TNF-a change in Dirac voltage as a function of
concentration.
Table 5.2: Average shift in Dirac voltage for TNF-a selectivity static sensing with 0.01 × PBS as
liquid gate and VDS = 100 mV.
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Average shift in Dirac voltage (mV)
10 pM
100 pM
1 nM
10 nM
100 nM

106.580333
49.151000
49.198000
81.943000
98.385667

Figure 5.5 summarizes the results from the selectivity testing of the biosensor. While IL-6
does significantly change the Dirac voltage and specifically follows the Hill-Langmuir equation,
the TNF-a proves to cause a relatively small shift in Dirac voltage. The average change in Dirac
voltage was 106.58 mV, 49.151 mV, 49.198 mV, 81.943 mV, and 98.386 mV for increasing levels
of TNF-a as displayed in Table 5.2. These changes, while small in comparison to the shift due to
IL-6 introduction, are also random in magnitude. For example, in Figure 5.5(B) the largest shift in
Dirac voltage due to TNF-a concentration is at 10 pM and the smallest shift is at 100 pM.
Therefore, the shift in Dirac voltage is independent of the concentration of TNF-a that is
introduced. These results conclude that the aptamers chosen are highly selective to the Interleukin6 recombinant mouse protein. The error bars are generated with N = 3 devices and they represent
one standard error for the TNF-a data in Figure 5.5(B).
The limit of detection (LoD) is the lowest analyte concentration which is likely to be
reliably measured [70]. The limit of detection can be calculated for any given device using the
equation presented below [23].
Limit of Detection =

+.+ . /0)*1)21 134')0'5* )0 063 7583/0 95*93*02)0'5* :3)/;231
<75=3 5> 063 9)7'?2)0'5* 9;243 ()0 7583/0 95*93*02)0'5*)

Using this equation, the GFET biosensor can be assessed for what the range of detection will be
and the reliability of those results. The limit of detection is measured for both the case where the
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liquid gate is the 0.01 × PBS buffer and when the liquid gate is the target analyte. The limit of
detection for these two cases are 14.7292 pM and 24.5399 pM respectively.
5.3.3. SENSING UNDER MECHANICAL STRESS
A wearable device needs to be able to withstand material deformations while its
performance integrity stays intact. Other Mylar-based biosensors have proven to be able to
withstand deformations such as substrate bending [6], [54], twisting, and stretching [10]. It is vital
that the wearable sensor results are not impacted if the sensor is bent. While the bending of the
substrate with bare graphene was tested to see if there was a resulting shift in Dirac voltage, it is
even more crucial to investigate if the trend of the sensing results stands true even when the
substrate is bent. The GFET device was placed on a substrate with a radius of 2.25 cm and the
static sensing process was repeated as shown in Figure 5.6(A). The target analyte was used as the
liquid gate and a drain-to-source voltage of 10 mV.
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Figure 5.6: (A) k-GFET IL-6 static sensing results while substrate is bent at radius of 2.25 cm and
VDS = 10 mV; (B) Normalized transfer characteristic curves showing a right shift in Dirac voltage
with respect to concentration; (C) Concentration calibration curve showing change in Dirac
voltage as a function of concentration.
From Figure 5.6(B) and (C), the conclusion can be drawn that the GFET-based IL-6 sensor still
performs reasonably well even under the mechanical stress of bending. Figure 5.6(B) shows the
transfer characteristic curves while the device is bent, and it can be seen that the Dirac voltage
shifts to the right as the concentration of IL-6 increases. Figure 5.6(C) displays that there is still a
distinct change in the Dirac voltage that is proportional to the concentration of IL-6 that is
introduced. The error bars are generated with N = 5 devices and they represent one standard error.
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The results indicate that there is still a significant shift of almost 1 V throughout the duration of
the experiment.
N=4
N=5

Average shift in Dirac
voltage (mV)
Flat
Bent
10 pM 530.612250 150.007000
100 pM 709.168500 300.000200
1 nM
816.320750 316.665200
10 nM 995.505250 495.833800
100 nM 1012.73350 995.833400

Figure 5.7: (A) Calibration curve with IL-6 sensing done with k-GFET on flat substrate (purple)
and on bent substrate (orange); (B) Side by side comparison of flat versus bending shift in Dirac
voltage as a function of concentration.
As shown in Figure 5.7(A), although the mechanical stress on the substrate does not cause
inconsistencies with the general trend which is displayed during sensing, it does impact the
individual changes in Dirac voltage. Figure 5.7(B) displays the average shift in Dirac voltage for
each case. The case when the substrate is flat shows over double the shift in Dirac voltage except
for at 100 nM where the measurements are almost identical. The error bars are generated with N
= 4 devices and N = 5 devices for the flat and the bending cases, respectively, and they represent
one standard error. The Dirac voltage shifts much less in the case when the substrate is bent in
comparison to the flat substrate. Therefore, bending does impact the sensor sensitivity and can
cause variation in the sensor data.

56

5.4.

REAL-TIME SENSING
Real-time sensing and its implementation are key to the GFET biosensor being widely used

in practical applications. Real-time sensing is essential as it will monitor the biomarker
continuously through the use of a wearable device. The device is first functionalized in the same
way as above, using the droplet method, and then the aptamers are attached. In real-time sensing
the gate-to-source voltage is fixed, and the drain current is simply monitored versus time. Due to
the relationship between Dirac voltage and concentration, by monitoring the drain current, the
concentration of target protein IL-6 present can be determined. During real-time sensing, the gateto-source voltage is fixed relative to the Dirac voltage. The Dirac voltage is determined after the
attachment of PBASE and aptamers using the static method for observing the existing transfer
characteristic curve. Once the Dirac voltage is determined, the gate-to-source voltage is chosen
appropriately. Moreover, the gate-to-source voltage should be fixed approximately ±500 mV from
the Dirac voltage as it provides sufficient differences in the individual equilibrium currents for
each of the target concentrations. In real-time sensing, a microfluidic channel is integrated in order
to introduce analyte and buffer solutions continuously.
Microfluidic channels not only allow for the continuous introduction of protein samples,
but also provide a plethora of other advantages over other common sensing methods. The dropletbased technique which is used for the static sensing mentioned throughout Section 5.3 is sufficient
for initial measurements and proof of concept however, there are inconsistencies that can arise
from this method which are effectively eliminated when implementing microfluidics. Evaporation
is a common problem with the droplet-based technique. Throughout the static process each droplet
incubates on the GFET surface for over 30 minutes. Such extensive time with the droplet sitting
static on the device can lead to evaporation of the analyte and subsequent inconsistencies with how
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much liquid is present in the liquid gate. By implementing a system like a microfluidic channel,
the effects of evaporation are significantly lessened due to the complete enclosure of the liquid
along with the slow yet constant flow rate [65].

Figure 5.8: Microfluidic channel used in real-time sensing with dimensions of 600 𝜇M width and
100𝜇M height.
Microfluidics allows for real-time sensing applications to be possible. This is because of
the continuous fluid flow across the conduction channel. In this application, a microfluidic channel
was fabricated using PDMS and the cast molding technique. The channel used in the application
has a width of 600 𝜇M and a height of 100𝜇M. The preparation and method of fabrication of the
microfluidic channel is directly outlined in the supplementary material from [23]. The microfluidic
channel used in the real-time sensing applications is shown above in Figure 5.8.
The process for real-time sensing of IL-6 is similar to the static measurement process. In
the real-time sensing LabVIEW VI, there are far fewer settings including only: compliance current
for the maximum drain-source current, the drain-to-source voltage, and the data interval relating
to how often samples should be taken. The gate-source voltage is fixed for real-time sensing and
the external power supply is used to provide this voltage to the device. Once set up, the real-time
monitoring can only track one out of five devices at a time so the most reliable one is selected and
will be used for continuous sensing. The difference is that instead of introducing the sample or
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buffer in a droplet form, it is introduced in the microfluidic channel and flowed through using a
PHD Ultra syringe pump by Harvard Apparatus. The current is then monitored versus time and
trends begin to form. Ideal measurements for the real-time sensing would look like the results
drawn below in Figure 5.9.

Figure 5.9: Ideal IDS versus time graph with increasing protein concentration injections.
The model response for real-time measurements would begin with a buffer solution that is
introduced to the system. The buffer continues to flow at a constant rate until an equilibrium
current is reached. Once the equilibrium is reached and identified, the first concentration of
Interleukin-6 is introduced. When the first concentration is introduced, which is 10 picomolar in
this case, the current will drop quite rapidly once the proteins begin binding with the aptamers.
Eventually the current will reach a new equilibrium current that is consistent with the new state of
the device. After the new equilibrium current is reached, the same process will be followed again
as the next highest concentration of IL-6 will be introduced until the next equilibrium current is
reached. As each new concentration is introduced and each new equilibrium current is identified,
the trend should follow the same as the static measurements, meaning that with increasing
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concentrations of IL-6 introduced, there should be a proportional drop in equilibrium current of
the device over time.

Figure 5.10: Real-time measurements. (A) IDS versus time with various IL-6 injections; (B) Change
in IDS with respect to concentration.
It is observed during real-time sensing that the trend seen during static sensing holds true
as exemplified in Figure 5.10. When a concentration of Interleukin-6 is introduced to the device,
the current drops in response as predicted in the ideal scenario. When the next concentration of IL6 is flowed, the same response is seen as more IL-6 proteins bind to the available aptamers on the
graphene surface. Consistent with the results from static sensing, with the gate-to-source voltage
fixed on the right side of the Dirac voltage, the current drops with each continuous injection of IL6 as outlined in Figure 5.10(A). Figure 5.10(B) displays the average change in drain-to-source
current during sensing for three devices. Figure 5.10(B) is generated by taking the difference in
the buffer solution equilibrium current and the equilibrium current for each of the specified
concentrations and plotting each against the concentration. The results are again consistent with
the data presented in the static sensing section as with increasing concentration there is a
proportional increase in the change in drain-to-source current that is recorded.
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5.5.

IMPLEMENTATION

OF

INTEGRATED

CURRENT

MEASUREMENT

PLATFORM
In order for the biosensor to be a wearable device, the bulky source measurement unit,
power supply, micromanipulator, and computer with the LabVIEW program must be removed
from the design and replaced with a much smaller and portable device containing a power supply
and the electrical measurement system. The miniature device was designed and implemented by
Professor Md. Shaad Mahmud’s research group at the University of New Hampshire, and it is able
to measure the drain-to-source current in a small and compact design as shown in Figure 5.11.

Figure 5.11: The k-GFET sensor shown with the integrated current measurement platform
developed by Prof. Md. Shaad Mahmud’s group.
One of the major problems when measuring a low voltage current in the micro or nano ampere
range is burden voltage. Burden voltage is the voltage drop across a shunt resistor as current passes
through. This can result in significant loss of resolution and accuracy. Prof. Mahmud’s group
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developed a custom made analog front end (AFE) using ultra-low offset (<50µV), low noise
precision amplifier (< -90dBV). The AFE is operated with zero bias voltage, to continually correct
for the DC offset voltage of the main amplifier. Afterward, the signal is fed into a 24-bit analog to
digital converter with digital filtering. The output data rate is programmable, with the slowest
speed (4.17 Hz) giving the lowest noise of 40 nV, which is negligible compared to other sources
of noise. The device operates by simply recording the drain-to-source current overtime and taking
samples every 500 msec. This portable measuring system records the data and currently sends it
to a laptop computer via a USB cable. The first implementation of the wearable device was created
on a rigid PCB substrate. The initial measurements are done to ensure integration is possible and
that the device works as anticipated when paired with the GFET biosensor.
When implementing an integrated current measurement platform to the k-GFET device, it
is vital that the data measured in this integrated platform closely matches that obtained with the
Keysight source measure unit. In order to validate that the on-device measurement system is
accurate, measurements of a k-GFET device were taken using the traditional method of the
Keysight source measure unit and LabVIEW program at the same time as using the new integrated
device. Because the devices are both measuring the drain-to-source current, the devices are simply
connected in series at the source terminal. The two were then compared in order to ensure that they
matched closely enough to conclude that it was working properly. Characterizations were obtained
using an external voltage supply to the device while both the integrated platform and external
measurement system recorded the drain-to-source current while the gate-to-source voltage was
swept. Three FETs were characterized for three individual k-GFET devices giving a set of nine
total measurements. As can be seen below in Figure 5.12, the current measured by the on-device
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platform matches very closely to the measurements obtained with the Keysight instrument in
connection with the LabVIEW program.

Figure 5.12: Comparison of integrated microcontroller measurements versus external current
meter. (A) IDS versus VGS transfer characteristic curve; (B) Dirac voltage location with N = 3 reps
per device.
Figure 5.12(A) displays one of the characterizations shown with both the integrated
microcontroller and external current meter, that best displays the common differences between the
two measuring systems. As shown in Figure 5.12(B), the Dirac voltage is very similar in when
comparing all three devices. The integrated microcontroller, in all three cases, measured a Dirac
voltage about 100 mV higher than the external current meter. Similar to Figure 5.12(A), Figure
5.12(B) also displays a small rightward shift in the case when the integrated microcontroller is
used. The integrated controller also has a small offset in terms of the drain-to-source current that
was measured. Finally, the integrated microcontroller does have a slightly higher noise and
variation in the measurement compared to the conventional setup.
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5.6.

CHARACTERIZATION TECHNIQUES AND MEASUREMENT SETUP
Measurements for both static and real-time measurements were collected using a

Micromanipulator (450 PM-B) probing station in combination with a Keysight precision
source/measure unit (B2902A) and National Instruments LabVIEW FET measurement programs.
LabView is a graphical programming language created by National instruments which allows for
the creation of VIs or virtual instruments that can control a variety of different lab equipment. For
this research two independent VIs were used; one for static measurements which swept the gateto-source voltage and records the corresponding drain currents and another for real-time sensing
which records the drain current over time. In the static VI, there are multiple different settings and
choices to make before running the VI. The drain voltage must be set, the maximum and minimum
sweeping voltage, compliance currents as well as the number of steps that the voltage will be swept
in. For static measurements, the gate-to-source voltage was swept to a range dependent on the
location of the Dirac voltage. In the majority of cases, the gate-to-source voltage was swept from
-2 V to 3.5 V. The liquid gate in all scenarios consists of a liquid droplet of 180 𝜇L and to ensure
consistency an eco-flex rubber well was mounted to each device to contain the droplet. The leakage
current at the gate electrode was monitored during all static sensing and remained less than 6 𝜇A,
3 𝜇A, and 0.9 𝜇A for the bare graphene measurements, buffer liquid gate sensing, and analyte
liquid gate sensing respectively. The leakage is considered negligible as the magnitude of the
drain-to-source current in these applications were more than 50 times higher than each of the
respective leakage currents.
The real-time measurements also utilize a GW Instek laboratory DC power supply, a 600
µm by 100µM polydimethylsiloxane (PDMS) microfluidic channel, and a PHD Ultra syringe
pump by Harvard Apparatus. For real-time measurements the gate-to-source voltage is set
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dependent on the location of the Dirac voltage. It is set to approximately 1.3 V in this application
along with the drain-to-source voltage set to 100 mV. The flow rate is set to 20 𝜇L and each
concentration is exposed to the graphene nano sensor for 45 minutes.
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CHAPTER 6: CONCLUSION
In this work, the feasibility of a GFET-based wearable and flexible biosensor is
investigated. The printable GFET device presented in this work is novel and opens the doors for
low cost and easy fabrication of wearable biosensors. Using the Voltera V-One PCB printer for
fabrication of a biosensor has been demonstrated in this work for the first time. This work has
displayed the successful detection of Interleukin-6 using the printed k-GFET platform in both static
and real-time measurements. The device is proven to be selective to the IL-6 target protein and
shows a high tolerance to mechanical stress on the substrate. Finally, the k-GFET platform can
easily be integrated with other miniaturized electronic components for current measurement. By
incorporating the GFET-based biosensor with the integrated current measurement platform, the
proposed device technology is just one step closer to being a truly wearable, stand-alone GFETbased biosensor.
FUTURE WORK
Although the basic implementation and feasibility have been demonstrated in this work,
further research and development are needed before this technology can be used in real world
applications. The integrated platform for measuring the current through the device is currently still
being fabricated on a rigid PCB substrate. In the future, the integrated platform will be created on
the same bendable Kapton substrate that the GFET biosensor is fabricated on. Furthermore, the
integrated platform will conveniently send the measured data to the user’s smartphone application
via wireless Bluetooth connection for easy monitoring. This will allow the data to be available at
the touch of a button, and therefore the measurements and the health information will be accessible
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to the user at any time. Future work will also include creating a portable way to supply two
individual voltages to the GFET platform, namely the drain-to-source voltage and the gate-tosource voltage. By fabricating the GFET, the power supply, and the current measurement system
all on the same substrate, each component of the platform could be seamlessly integrated. With a
unit that can supply voltages and measure currents worked into the device, the source/measure
unit, the power supply, the desktop computer with LabVIEW program, and the Micromanipulator
can be removed from the design and thus a compact and truly wearable system can be realized.
Possible work in the future will be extending this work into the field of stretchable
electronics as the Dycotec ink for printing is bendable and stretchable. With a stretchable platform,
the device could be fabricated on a stretchable substrate such as PDMS. Thus far, there has been
little development on GFETs directly fabricated onto a PDMS substrate and therefore such work
could lead to a new and innovative device platform.
Static measurements are vital to the beginning stages of research as it provides a proof of
concept and the building blocks for the remainder of the work to be done including real-time
sensing. Therefore, the static measurement LabVIEW program needs to be modified moving
forward. The program, regardless of sweeping range, begins at 0 volts, sweeps to the maximum
voltage in the half of the number of steps specified, then sweeps back to zero again in the other
half of the number of steps, then from 0 to the minimum voltage and then back again. Because the
program runs this way, it results in both a forward sweep and a backward sweep. The forward
sweep is defined from the minimum voltage swept to the maximum voltage and the backward
sweep is defined as the maximum voltage swept to the minimum voltage. For analysis however,
we choose the backward sweep as in the way the program is currently defined it is continuous,
where the forward sweep is broken into two parts as can be seen in Figure 6.1 below.
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Figure 6.1: Full sweep from LabVIEW showing full backward sweep and two-part forward sweep.
In addition to the issue of a broken forward sweep, the program also does not evenly divide the
number of steps across the entire sweeping voltage range but instead allots half of the steps of each
sweep for above zero volts and half of the steps in each sweep for below zero volts. This can cause
inconsistency as the step size can vary on either side of the sweep if the maximum and minimum
sweeping values do not have the same absolute value.
Future work should also include a system in which truly identical GFET devices can be
printed each time using the Voltera. When the devices are made, there is a large amount of human
interaction and human dependency. During the Voltera printing of the device, while the pattern is
identical each time, there is very little control over how thick or thin the line traces truly are. While
KiCAD does allow for the line width to be selected, once Voltera begins to print it, there is a level
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of uncertainty as the ink flow rate, printing speed, and printing height are all able to be controlled
by the user and could result in differences. After printing of the device, the graphene is transferred
onto the substrate. This is another place where there can be a small level of inconsistency device
to device. The graphene comes in 1 cm-by-1 cm square films. This film is then cut into four
approximately even sub-squares and one square is used per device. This can cause the graphene
shapes to vary slightly. When the graphene is transferred onto the device itself it is also impossible
to get the graphene to fall in the same place on the electrodes each time. With all these factors
considered, currently there is still a high yield rate for the devices at approximately 75% of devices
working with feasible Dirac voltages. With such promising results now, further advancements in
reliability and wearability could make the proposed printed and fabricated GFET-based biosensors
a technology of the future in the field of wearable health diagnostic platforms.
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APPENDIX
LabVIEW code:
Every LabVIEW code consists of both a front panel and a block diagram.
Static sensing file: front panel
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Static sensing file: block diagram
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Real-time sensing file: front panel
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Real-time sensing file: block diagram
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Voltera printing procedure:
Voltera outlines the printing procedure and walks the user simply through each of the steps
to print a design. All steps are outlined below and are as follows for this application:
1. Open Voltera software which brings the user to the front page. Select print.
2. Voltera allows for two different printing processes
Simple: Printing design on a blank substrate
Aligned: Priting design on a substrate with existing features
For this application, simple printing is used.
3. Choose the ink which is being used for the application. Currently Voltera only allows selection
of Voltera brand inks, however this selection is only used to automatically select the temperature
and time of curing at the end of the process. Therefore, other commercially available inks can be
used and manually cured at the end using the heat function of the Voltera.
4. Load in the file that is to be printed (from KiCAD).
5. Quality check ensures success during the printing process. This includes making sure that the
calibration pad does not have dried ink on it or that the nozzle tip is bent or broken.
6. The substrate is secured into place on the Voltera stage using the provided clamps. In this case,
the Kapton substrate is too thin to be securly ancored to the stage using the clamps so a small
amount of Kapton tape is used.
7. Mount the probe tip to the Voltera. The Voltera comes with two ‘pens’ one of which is for the
conductive ink and the other which is the probe (green top).
8. Position the circuit to align properly with the secured substrate. The user estimates where the
substrate is on the Voltera stage from the software. From there after selecting the ‘outline’ button,
the Voltera probe will hover over the Voltera stage and outline the area where circuit design will

89

print. If the estimate of the substrate location is accurate then the user proceeds to the next step. If
not, the user simply adjusts the positioning on the Voltera software until the probe properly outlines
the substrate.
9. After proper positioning, the probe measures the substrate height. This is a critical step as the
Voltera print height is not set from the stage height, but rather is set to be relative from the surface
of the substrate to be printed on.
10. Priming the conductor consists of the user turning the gear on the top of the conductor until
ink begins to come out the nozzle. After the ink comes out, the gear is turned back about a ¼ of a
turn and then the nozzle is whipped clean and placed onto the Voltera.
11. Calibration of the conductor ensures proper printing during the next step. During calibration,
a standard 4 serpentine and 4 straight line pattern is printed. The user watches as this pattern is
printed to ensure that the ink is coming out at a proper rate and that the print height is appropriate.
If the calibration pattern is not printed properly or to the users liking, it can simply be wiped away
and repeated until it is acceptable. This step is encouraged to be repeated as many times as
necessary to ensure that the final design only needs to be printed once, thus saving time and
materials.
12. Print the pattern using the conductive ink. During this step, the entire design can be printed, or
just certain sections making touchups extremely easy.
13. Lastly, heating is done in order to cure the ink. If the proper ink is selected during step three,
the heating function at the end of the printing process is acceptable to use. If this is not the case,
the user can close the printing function and select the heating function from the front page. The
heat function has a manual mode which allows for the user to select both the temperature and
duration of the ink curing
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